• HOME
  • ABOUT US
  • TUMOR IMMUNE THERAPY
    • Introduction
    • Cancer Immunotherapy Type
  • NBRL CELL & GENE DRUG R&D
    • Introduction
    • NBRL Cell & Gene Drug
    • Intrabody Development
    • Alzheimer’s Disease
    • Next Step Development
  • CONTACT US
  • More
    • HOME
    • ABOUT US
    • TUMOR IMMUNE THERAPY
      • Introduction
      • Cancer Immunotherapy Type
    • NBRL CELL & GENE DRUG R&D
      • Introduction
      • NBRL Cell & Gene Drug
      • Intrabody Development
      • Alzheimer’s Disease
      • Next Step Development
    • CONTACT US
  • HOME
  • ABOUT US
  • TUMOR IMMUNE THERAPY
    • Introduction
    • Cancer Immunotherapy Type
  • NBRL CELL & GENE DRUG R&D
    • Introduction
    • NBRL Cell & Gene Drug
    • Intrabody Development
    • Alzheimer’s Disease
    • Next Step Development
  • CONTACT US

CURRENT CANCER IMMUNE THERAPY

I

Introduction

Immunotherapy is a method of treating cancer. The treatment utilizes the body’s own immune system capabilities to kill cancer cells by strengthening or restoring the body’s immune system and to prevent cancer both from returning after treatment and from spreading to other parts of the body.    

NBRLBoston Novel Technology Platform

Human Nanobody Discovery

Bi/Multi Specific Antibody Engineer

Bi/Multi Specific Antibody Engineer

A > 10^11 human VH nanobody phage library for high affinity human nanobody ( 15 Kd) discovery

Bi/Multi Specific Antibody Engineer

Bi/Multi Specific Antibody Engineer

Bi/Multi Specific Antibody Engineer

Novel Bi-specific and multi-specific antibody and Fc based therapeutic fusion protein engineering tech platform 

Pro/Mask-Antibody Engineer

Bi/Multi Specific Antibody Engineer

Pro/Mask-Antibody Engineer

generating the pro/masking-antibody to reduce the Side effects of the Ab drugs caused by systemic on-target toxicity and work in TME more efficiently 

Copyright © 2023 NBRLBoston - All Rights Reserved

  • HOME